Live Breaking News & Updates on Doctors Choose Covishield

Serum Institute of India CEO Adar Poonawalla takes COVID vax shot
Resident doctors at Delhi s Ram Manohar Lohia (RML) Hospital on Saturday expressed reservations over taking Bharat Biotech s Covaxin due to its incomplete clinical trial data and requested the hospital administration to vaccinate them with the Oxford Covid-19 vaccine Covishield .
In a letter to the medical superintendent, the doctors wrote, The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination. We request you to vaccinate us with Covishield which has completed all stages of the trial before its rollout. ....

Ak Singh Rana , Oxford Covishield , Oxford Covid , Satyendar Jain , Adar Poonawalla , Randeep Guleria , Ram Manohar Lohia , Nirmalaya Mohapatra , Delhi Health , Serum Institute Of India , Resident Doctors Association , Serum Institute , Bharat Biotech , Kalawati Saran Children , Medical Superintendent , Director Dr Randeep Guleria , Delhi Health Minister Satyendar Jain , Covaxin Trials , Vaccine For Covid , Covishield Or Covaxin , Which Vaccine Is Safe , Doctors Choose Covishield , Delhi Doctors Choose Covishield , Covaxin Vs Covishield , அடார் பூனாவல்ல , ரந்தீப் குலேரியா ,